摘要
目的：探讨影响子宫肉瘤生存率的因素。方法：对101例子宫肉瘤临床病例资料，使用COX比例风险模型及Logr-nank检验方法，分别进行多因素及单因素分析、结果：COX模型多因素预后分析表明，对子宫肉瘤患者影响其生存率的主要因素是临床分期、病理分类、绝经情况，子宫大小是一项次要因素。Ⅰ，Ⅱ期的预测5年生存率为58％，Ⅲ期为34％，Ⅳ期为23％。平滑肌肉瘤的5年生存率为45％，中胚叶混合肉瘤为34％，宫内膜间质肉瘤为28.9％。结论：子宫肉瘤患者影响生存期的主要因素是临床分期、病理分类、绝经情况三项，子宫大小是一项次要因素。
Purpose: To evaluate the significant prognostic factors related to survival in patients with uterine sarcoma, Method:Analysis of prognostic factors was performed by COX'S proportional hazard model and logank logarithmie series test method in 101 cases with uterine sarcoma. Results: The 5-year survival rate was 58% in clinical stage Ⅰ,Ⅱ, 34% in clinical stage Ⅲ, 23% in clinical stage Ⅳ. The 5-year survival rate 45% in leiomyosarcoma, 34% in mesodermal haxed sarcoma, 72. 5 % in endometrial stromal sarcoma. Conclusion: The major significant prognostic factors related to survival are clinical staging, histopathologic type and menopausal status. The size of uterus is a minor factor.
